Watch Demo

Canada Cardiovascular Drug Industry Outlook 2022 - 2026

See how Canada Cardiovascular Drug performed compared to key markets such as Germany and Italy.

Key Market Indicators

Canada's beta blocking medicine sales are expected to reach $200 million by 2026. In 2021, the country was ranked third in the world, with sales of $231 million. However, this figure represents a 2% year-on-year decrease from 2017. Italy overtook Canada in 2021 with sales of $231 million, while Australia was fourth with sales of an unknown amount.

Marketing Banner

Canada Cardiovascular Drug Market Data and Forecasts

How much will Canada Cardiovascular Drug Market grow to 2026?

Forecast: Calcium Channel Blocking Medicine Sales in Canada
Forecast: Cardiac Glycosides Sales in Canada
Forecast: Cardiovascular System Medicine Sales in Canada
Forecast: Calcium Channel Blocking Medicine Sales in Canada
Forecast: Renin-Angiotensin System Medicine Sales in Canada
More in Cardiovascular Drug Industry for 2028

Improve your Knowledge with the latest Indicators and Trends